For help on how to get the results you want, see our search tips.
997 results
Keyword cancer Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Abiraterone Accord (new)
abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 26/04/2021,
, Authorised, Last updated: 05/05/2021
Abiraterone Accord is a cancer medicine used to treat men … with metastatic prostate cancer. This is cancer that affects the prostate … system). It is used when the cancer has spread to other parts … -
List item
Human medicine European public assessment report (EPAR): Evrysdi (new)
Risdiplam, Muscular Atrophy, Spinal
Date of authorisation: 26/03/2021,
, 
, Authorised, Last updated: 04/05/2021
-
List item
Human medicine European public assessment report (EPAR): Pemazyre (new)
pemigatinib, Cholangiocarcinoma
Date of authorisation: 26/03/2021,
, , 
, Authorised, Last updated: 04/05/2021
pemigatinib Overview Pemazyre is a cancer medicine used to treat adults … cholangiocarcinoma (biliary tract cancer or cancer of the bile ducts) when the cancer cells have an abnormal form … used for? Pemazyre is a cancer medicine used to treat adults … -
List item
Human medicine European public assessment report (EPAR): Jemperli (new)
dostarlimab, Endometrial Neoplasms
Date of authorisation: 21/04/2021,, , Authorised, Last updated: 03/05/2021
Jemperli is a cancer medicine for treating certain … certain types of endometrial cancer cancer of the womb) that are advanced … involving a platinum-based cancer medicine. Jemperli is for … -
List item
Human medicine European public assessment report (EPAR): Thiotepa Riemser (new)
thiotepa, Hematopoietic Stem Cell Transplantation, Neoplasms
Date of authorisation: 26/03/2021,, Authorised, Last updated: 30/04/2021
a blood disease such as a cancer of the blood (e.g. leukaemia … multiply rapidly, such as cancer of progenitor (or ‘stem’ … a blood disease such as a cancer of the blood (e.g. leukaemia … -
List item
Human medicine European public assessment report (EPAR): Alymsys (new)
bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 26/03/2021,, 
, Authorised, Last updated: 26/04/2021
Alymsys is a cancer medicine that is used to … adults with the following cancers: cancer of the colon (large bowel … parts of the body; breast cancer that has spread to other … -
List item
Human medicine European public assessment report (EPAR): Retsevmo (new)
Selpercatinib, Carcinoma, Non-Small-Cell Lung, Thyroid Neoplasms
Date of authorisation: 11/02/2021,, , Authorised, Last updated: 23/04/2021
Retsevmo is a cancer medicine for use in patients … for use in patients whose cancer is caused by changes in a … used for? Retsevmo is a cancer medicine for use in patients … -
List item
Human medicine European public assessment report (EPAR): Byfavo (new)
remimazolam, Conscious Sedation
Date of authorisation: 26/03/2021,, Authorised, Last updated: 20/04/2021
-
List item
Human medicine European public assessment report (EPAR): Kesimpta (new)
ofatumumab, Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 26/03/2021,, Authorised, Last updated: 16/04/2021
weakened immune systems or cancer. For the full list of restrictions … weakened immune systems or cancer. For the full list of restrictions … -
List item
Human medicine European public assessment report (EPAR): Oyavas (new)
bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 26/03/2021,, , Authorised, Last updated: 15/04/2021
Oyavas is a cancer medicine that is used to … adults with the following cancers: cancer of the colon (large bowel … parts of the body; breast cancer that has spread to other … -
List item
Human medicine European public assessment report (EPAR): Sogroya (new)
Somapacitan, Growth
Date of authorisation: 31/03/2021,, Authorised, Last updated: 15/04/2021
tumours must be inactive and cancer therapy must have been completed … tumours must be inactive and cancer therapy must have been completed … -
List item
Human medicine European public assessment report (EPAR): Vazkepa (new)
Icosapent ethyl, Dyslipidemias
Date of authorisation: 26/03/2021, Authorised, Last updated: 14/04/2021 -
List item
Human medicine European public assessment report (EPAR): Sunitinib Accord
sunitinib, Gastrointestinal Stromal Tumors, Carcinoma, Renal Cell, Neuroendocrine Tumors
Date of authorisation: 11/02/2021,, , Authorised, Last updated: 06/04/2021
adults with the following cancers: gastrointestinal stromal … tumour (GIST), a type of cancer of the stomach and bowel … treatment with imatinib (another cancer medicine) has failed; metastatic … -
List item
Human medicine European public assessment report (EPAR): Gamifant
Emapalumab, Immune System Diseases
Date of refusal: 07/01/2021,, Refused, Last updated: 23/03/2021
infection or in association with cancer (so-called secondary HLH … -
List item
Human medicine European public assessment report (EPAR): Kixelle
insulin aspart, Diabetes Mellitus
Date of authorisation: 05/02/2021,, , Authorised, Last updated: 16/03/2021
-
List item
Human medicine European public assessment report (EPAR): COVID-19 Vaccine Janssen (updated)
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S), COVID-19 virus infection
Date of authorisation: 11/03/2021,, , Revision: 2, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Lumoxiti
Moxetumomab pasudotox, Leukemia, Hairy Cell
Date of authorisation: 08/02/2021,, , Authorised, Last updated: 09/03/2021
Lumoxiti is a cancer medicine used to treat adults … with hairy cell leukaemia, a cancer of the white blood cells … treatment with a type of cancer medicine called purine nucleoside … -
List item
Human medicine European public assessment report (EPAR): Onbevzi
bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 11/01/2021,, , Authorised, Last updated: 05/03/2021
Onbevzi is a cancer medicine that is used to … adults with the following cancers: cancer of the colon (large bowel … parts of the body; breast cancer that has spread to other … -
List item
Human medicine European public assessment report (EPAR): Inrebic
fedratinib dihydrochloride monohydrate, Myeloproliferative Disorders, Primary Myelofibrosis
Date of authorisation: 08/02/2021,, , Authorised, Last updated: 03/03/2021
myelofibrosis (a rare form of blood cancer) who have enlarged spleen … experienced in the use of cancer medicines. Inrebic is available … myelofibrosis (a rare form of blood cancer) who have enlarged spleen … -
List item
Human medicine European public assessment report (EPAR): Heplisav B
hepatitis B surface antigen, Hepatitis B
Date of authorisation: 18/02/2021,, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Ogluo
Glucagon, Diabetes Mellitus
Date of authorisation: 11/02/2021, Authorised, Last updated: 26/02/2021 -
List item
Human medicine European public assessment report (EPAR): Yuflyma
adalimumab, Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Crohn Disease, Arthritis, Juvenile Rheumatoid, Hidradenitis Suppurativa, Uveitis
Date of authorisation: 11/02/2021,, Authorised, Last updated: 26/02/2021
fight off infections and cancer, and there have been some … serious infections and blood cancers in patients using adalimumab … fight off infections and cancer, and there have been some … -
List item
Human medicine European public assessment report (EPAR): Tukysa
Tucatinib, Breast Neoplasms, Neoplasm Metastasis
Date of authorisation: 11/02/2021,, Authorised, Last updated: 18/02/2021
Tukysa is a cancer medicine that is used to … that is used to treat breast cancer that is locally advanced … HER2-positive. This means the cancer cells produce a protein on … -
List item
Human medicine European public assessment report (EPAR): Lenalidomide Krka
lenalidomide hydrochloride monohydrate, Multiple Myeloma, Lymphoma, Follicular
Date of authorisation: 11/02/2021,, Authorised, Last updated: 18/02/2021
the treatment of certain cancers affecting blood cells, namely … the treatment of certain cancers affecting blood cells, namely … In multiple myeloma, a cancer of a type of white blood … -
List item
Human medicine European public assessment report (EPAR): Lenalidomide Krka d.d. Novo mesto
lenalidomide hydrochloride monohydrate, Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, Follicular, Lymphoma, Mantle-Cell
Date of authorisation: 11/02/2021,, Authorised, Last updated: 18/02/2021
the treatment of certain cancers and serious conditions affecting … the treatment of certain cancers and serious conditions affecting … In multiple myeloma, a cancer of a type of white blood …